VIENNA, 03-Mar-2016 — /EuropaWire/ — The INFINIX 4DCT from Toshiba Medical Systems Europe is making high-risk clinical cases easier, safer and faster. Interventional radiologists and other clinicians can get a close-up view of this state of the art angio-CT concept at ECR 2016 (European Congress for Radiology), March 2-6, in Vienna.
Cone-beam CT is a great tool but has several limitations particularly with regard to field of view, breathing instructions, resolution, and radiation dose.
In the past, when a patient underwent a high-risk intervention using conventional cone-beam CT but image quality was considered to be insufficient, he had to be transferred to a full-fledged CT scanner in another room – an interruption which could take up to an hour and left the patient vulnerable during the wait.
With Toshiba’s INFINIX 4DCT a full CT scan can be done immediately using a powerful hybrid imaging system that combines the world’s most flexible angio suite with the most advanced dynamic volume CT. It gives the medical team new capabilities for planning the intervention, treatment and follow-up.
INFINIX 4DCT can be configured with an angiography system and one of four Aquilion CTs: the 32-slice Aquilion Large Bore, the 160-slice Aquilion PRIME, the 640-slice Aquilion ONE and the 640-slice Aquilion ONE Vision Edition. Unique to the INFINIX 4DCT configuration with the 640-slice Aquilion ONE is the 16 cm full anatomical coverage that adds a fourth dimension to the 3D full volume scans by showing time lapse images in a cine model.
Toshiba’s signature wide detector CT technology with up to 16 cm coverage in a single rotation provides outstanding ability in a wide range of procedures including cardiac, neuro, interventional oncology and trauma.
It also brings a new dimension to procedures, such as gastric-intestinal (GI) bleeding, bronchial artery embolization, complex endoleak embolization or drainage. While, for example, locating a GI bleed can be very difficult in angio view or cone-beam CT due to motion artefacts caused by breathing, a CT scanner in the room instantaneously provides high-quality images.
The INFINIX 4DCT suite integrates Toshiba’s SUREGuidance for rapid, accurate target positioning be it to view a reference slice for pathology or to precisely target a position loaded from the angio image.
“Such a system with a CT scanner takes us one step further by acquiring anatomical and functional data simultaneously with high spatial and temporal resolution,” says René Degros, Business Unit Manager X-Ray Europe. “No other modality has this field of view and this level of detail.”
While clinicians may think they are covering an entire tumor with angio, INFINIX 4DCT shows signs of other arteries that might be feeding the tumor, Dugros points out. “It becomes easier to locate these extrahepatic feeders and ensure we treat the entire tumor.”
INFINIX 4DCT also incorporates DoseRite and AIDR3D functions that optimize image quality at low-dose exposures with iterative reconstruction and Toshiba’s Adaptive Diagnostics functionalities for bone-free contrast-enhanced imaging.
“Each intervention holds a risk,” says Degros. “Yet if we bring a CT scanner into the room, we have the option to do studies that can give us clear endpoints, to determine whether we have treated the patient’s condition sufficiently and not expose the patient to further risk caused by additional interventions.”
About Toshiba Medical Systems Europe
With headquarters in Zoetermeer, The Netherlands, Toshiba Medical Systems Europe (TMSE) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in Europe. For more information, visit the TMSE website at http://toshiba-medical.eu
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at http://www.toshibamedicalsystems.com
Toshiba Corporation, a Fortune Global 500 company, channels world-class capabilities in advanced electronic and electrical product and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future”, Toshiba promotes global operations and is contributing to the realization of a world where generations to come can live better lives.
Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 580 consolidated companies employing 199,000 people worldwide, with annual sales surpassing 6.6 trillion yen (US$55 billion). To find out more about Toshiba, visit http://www.toshiba.co.jp
SOURCE: Toshiba Medical Systems Europe B.V.